PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $45,000 | +2.3% | 646 | -11.1% | 0.00% | 0.0% |
| Q4 2020 | $44,000 | +12.8% | 727 | +12.9% | 0.00% | -33.3% |
| Q3 2020 | $39,000 | +254.5% | 644 | +211.1% | 0.00% | +200.0% |
| Q2 2020 | $11,000 | +57.1% | 207 | +6.2% | 0.00% | 0.0% |
| Q1 2020 | $7,000 | -22.2% | 195 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $9,000 | +28.6% | 195 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $7,000 | +16.7% | 195 | +48.9% | 0.00% | 0.0% |
| Q2 2019 | $6,000 | +500.0% | 131 | +322.6% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 31 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 31 | -8.8% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 34 | 0.0% | 0.00% | – |
| Q2 2018 | $2,000 | +100.0% | 34 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | -50.0% | 34 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | +100.0% | 34 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | – | 34 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
| Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
| GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
| ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
| RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
| AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
| 1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
| ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
| OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
| Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |